PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26346160-7	2015	The phosphorylation was observed at the serine and threonine residues of MARK4.	Serine	40-46	microtubule affinity regulating kinase 4	Homo sapiens	73-78	
34289095-1	2022	Microtubule affinity regulating kinase 4 (MARK4), an important member of the serine/threonine kinase family, regulates the phosphorylation of microtubule-associated proteins and thus modulates microtubule dynamics.	Serine	77-83	microtubule affinity regulating kinase 4	Homo sapiens	0-40	
34289095-1	2022	Microtubule affinity regulating kinase 4 (MARK4), an important member of the serine/threonine kinase family, regulates the phosphorylation of microtubule-associated proteins and thus modulates microtubule dynamics.	Serine	77-83	microtubule affinity regulating kinase 4	Homo sapiens	42-47	
34121218-1	2021	MAP/microtubule affinity-regulating kinase 4 (MARK4) is a member of serine/threonine kinase family and considered an attractive drug target for many diseases.	Serine	68-74	microtubule affinity regulating kinase 4	Homo sapiens	0-44	
34121218-1	2021	MAP/microtubule affinity-regulating kinase 4 (MARK4) is a member of serine/threonine kinase family and considered an attractive drug target for many diseases.	Serine	68-74	microtubule affinity regulating kinase 4	Homo sapiens	46-51	
32954123-1	2020	Microtubule affinity-regulating kinase 4 (MARK4), a member of the serine/threonine kinase family, is an emerging therapeutic target in anticancer drug discovery paradigm due to its involvement in regulation of microtubule dynamics, cell cycle regulation, and cancer progression.	Serine	66-72	microtubule affinity regulating kinase 4	Homo sapiens	0-40	
32954123-1	2020	Microtubule affinity-regulating kinase 4 (MARK4), a member of the serine/threonine kinase family, is an emerging therapeutic target in anticancer drug discovery paradigm due to its involvement in regulation of microtubule dynamics, cell cycle regulation, and cancer progression.	Serine	66-72	microtubule affinity regulating kinase 4	Homo sapiens	42-47	
32954123-3	2020	Compound 4h was identified as a promising MARK4 inhibitor with high selectivity toward MARK4 inhibition as compared to the panel of screened 30 kinases pertaining to the serine/threonine family, which was validated by molecular docking and fluorescence binding studies.	Serine	170-176	microtubule affinity regulating kinase 4	Homo sapiens	42-47